Overview
- The GoFundMe appeal opened on July 31 and secured over €25 000 from more than 120 contributors in its first hour.
- Organizers aim to raise $1.5 million to develop a tailored antisense oligonucleotide treatment under Dr. Shneider at Columbia University.
- Previous ASO therapies have worked against SOD1 and FUS ALS mutations, but Materazzi’s TDP-43 variant poses added scientific hurdles.
- Early backers include football community figures Gaia Lucariello, Edoardo Crnjar and Arianna Rapaccioni.
- Since his September 2024 diagnosis, the 49-year-old agent has rapidly lost mobility and faces respiratory decline due to the aggressive progression of his ALS.